Microbot Medical Partners with Lovell to Access Federal Healthcare
Microbot Medical Inc. has entered into an agreement with Lovell Government Services to expand the reach of its LIBERTY® Endovascular Robotic System to federal healthcare systems, including the VHA, MHS, and IHS. Lovell will act as the Company's Service-Disabled Veteran-Owned Small Business (SDVOSB) vendor, aiming to streamline the sales process and help government agencies meet procurement goals. The LIBERTY System is expected to be added to Lovell's Federal Supply Schedule (FSS) contract in Q3 2026 and will also be available through other federal procurement platforms. This partnership is anticipated to increase awareness and adoption of Microbot's technology among veterans and active-duty service members.
Key Highlights
- Microbot Medical partnered with Lovell Government Services to access federal healthcare systems.
- Lovell will serve as Microbot Medical's Service-Disabled Veteran-Owned Small Business (SDVOSB) vendor.
- The LIBERTY System will be added to Lovell's Federal Supply Schedule (FSS) contract.
- FSS contract activation is expected during the third quarter of 2026.
- The system will also be accessible through GSA Advantage, DLA ECAT, and DoD DAPA.
- Lovell serves thousands of government care sites, including 170 medical centers.
- Each site averages over 200 peripheral endovascular cases annually.
Price Impact
More from MBOT